Latest stock market podcasts

Between the BellsThe Bellcast
Between the Bells

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

Morning Bell 11 November

Bell Direct
November 11, 2025

Morning Bell 10 November

Bell Direct
November 10, 2025

Weekly Wrap 7 November

Bell Direct
November 7, 2025

Morning Bell 6 November

Bell Direct
November 6, 2025

Morning Bell 5 November

Bell Direct
November 5, 2025

From the Helm: Rural Funds Group (ASX:RFF), Tim Sheridan, COO & James Powell, GM

Bell Direct
November 4, 2025

Morning Bell 4 November

Bell Direct
November 4, 2025

Morning Bell 3 November

Bell Direct
November 3, 2025

Weekly Wrap 31 October

Bell Direct
October 31, 2025

Morning Bell 30 October

Bell Direct
October 30, 2025

Morning Bell 29 October

Bell Direct
October 29, 2025

From the helm: SenSen Networks Limited (ASX: SNS), Dr Subhash Challa, CEO

Bell Direct
October 28, 2025
  1. Pages:
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
  12. 10
  13. ...
  14. 146